EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?

Hélène Roux, Nicolas Chomont iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Hélène Roux und 1 weiteren Autor:innen. Beteiligte Einrichtung: Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV, HIV Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Canadian Institutes for Health Research, Réseau Sida et Maladies Infectieuses du Fonds de Recherche du Québec -.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistence of latent viral genomes in people receiving antiretroviral therapy (ART) is the main obstacle to a cure for human immunodeficiency virus (HIV) infection. Viral reservoirs can be defined as cells harboring HIV genomes that have the ability to produce infectious virions. Precise quantification of the cellular reservoirs of HIV is challenging because these cells are rare, heterogeneous, and outnumbered by a larger number of cells carrying defective genomes. In addition, measuring the inducibility of these proviruses requires functional assays and remains technically difficult. The recent development of single-cell and single-viral genome approaches revealed additional layers of complexity: the cell subsets that harbor proviruses are heterogeneous and their ability to be induced is variable. A substantial fraction of intact HIV genomes may be permanently silenced after years of ART, revealing the underappreciated importance of induction assays. As such, a simple approach that would assess simultaneously the genetic intactness and the inducibility of the reservoir is still lacking. In this study, we review recent advances in the development of methods to quantify and characterize persistently infected cells, and we discuss how these findings can inform the design of future assays aimed at measuring the size of the intact and inducible HIV reservoir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIVHIV InfectionsHumansCD4-Positive T-LymphocytesAnti-Retroviral AgentsProvirusesVirus LatencyViral Load

Stichwörter der Autor:innen

HIV DNAHIV reservoirinducibilityintact genomesviral rebound

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Centre de Recherche du CHUM, Montreal, Quebec, Canada.

ORCID-Profile: Nicolas Chomont

Förderung

  • NIAID NIH HHS
  • Canadian Institutes for Health Research
  • Réseau Sida et Maladies Infectieuses du Fonds de Recherche du Québec -
  • Santé

Zitieren

APA

Roux, H., & Chomont, N. (2024). Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad381

Vancouver

Roux H, Chomont N. Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad381

BibTeX
@article{Roux2024,
  author = {Roux, Hélène and Chomont, Nicolas},
  title = {Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad381}
}
Kostenlos starten →